Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease that manifests as acute relapses and progressive disability. As a primary endpoint for clinical trials in MS, disability is difficult to both characterize and measure. Furthermore, the recovery from relapses and the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavery, Amy M., Verhey, Leonard H., Waldman, Amy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026972/
https://www.ncbi.nlm.nih.gov/pubmed/24883205
http://dx.doi.org/10.1155/2014/262350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026972/
https://www.ncbi.nlm.nih.gov/pubmed/24883205
http://dx.doi.org/10.1155/2014/262350

Ejemplares similares